Ladapos Guidance Against Amalgam Dental Fillings Due to Mercury Concerns

Florida Surgeon General Dr. Joseph Ladapo has recently advised against the routine use of dental amalgam fillings due to potential risks associated with mercury exposure. Dental amalgam is a mixture of metals, with approximately half of its weight being elemental mercury, combined with a powdered alloy of silver, tin, and copper. While the Food and Drug Administration (FDA) acknowledges that mercury binds the alloy particles to form a durable filling, it also releases low levels of mercury vapor that can be inhaled and absorbed by various organs, leading to health concerns.

Studies have linked mercury exposure from dental amalgam fillings to DNA damage in blood cells and kidneys. Research suggests that these fillings contribute significantly to mercury deposits in human tissues, with estimates ranging from 60% to 95%. Recent studies, such as one involving 108 Jordanians in 2025, have shown elevated levels of mercury in the blood and urine of individuals with amalgam fillings, with levels correlating with the number of restorations. Dr. Ladapo emphasizes the availability of alternative filling materials such as composites, glass ionomer, stainless steel crowns, and permanent crowns, urging patients to discuss these options with their healthcare providers to choose the most suitable material for their needs.

It is important to note that intact fillings should not be removed unless deemed medically necessary, as the highest risk of mercury exposure occurs during the placement or removal of amalgam fillings. Despite Ladapo’s guidance, the FDA, American Dental Association, and other organizations maintain that dental amalgam is generally safe for the majority of the population, except for specific high-risk groups. These high-risk groups include pregnant women, as exposure to mercury from amalgam fillings has been associated with increased mercury levels in fetal and infant brain tissue, potential neurodevelopmental delays in children, and elevated mercury levels in maternal serum, cord blood, placenta, and breast milk.

Moreover, individuals with certain genetic variants, such as CPOX4, which is involved in the production of hemoglobin, myoglobin, and specific enzymes, may be more susceptible to mercury’s neurotoxic effects. Other high-risk groups identified by the FDA include individuals with preexisting neurological conditions, impaired kidney function, or known allergies to mercury, silver, copper, or tin. While the general consensus is that exposure to mercury from dental amalgam does not typically lead to adverse health effects in the general population, caution is advised for these high-risk groups. Dr. Ladapo’s guidance underscores the importance of informed discussions between patients and healthcare providers regarding the selection of appropriate dental filling materials to minimize potential risks associated with mercury exposure.

  • Dr. Ladapo recommends against routine use of dental amalgam fillings due to mercury exposure risks.
  • Alternative filling materials like composites, glass ionomer, and crowns are available and should be discussed with healthcare providers.
  • High-risk groups, including pregnant women and individuals with specific genetic variants or medical conditions, should exercise caution regarding dental amalgam fillings.
  • Removal of intact fillings should only be done if medically necessary to minimize mercury exposure risks.

Read more on wusf.org